Grantopen🌐 United StatesRFA-DA-26-034

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

National Institutes of Health

Details?

Posted: Nov 20, 2024
Response deadline: Nov 18, 2027, 12:00 AM UTC (494d)
Type: Grant
Category: 93.839, 93.837, 93.840, 93.855, 93.233, 93.279, 93.838
Status: open
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: RFA-DA-26-034

Doc Type: synopsis
Opp Status: posted

Similar open solicitations

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
United States · Nov 1, 2024
CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)
United States · May 4, 2026
Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
United States · Oct 4, 2024
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
United States · Sep 18, 2024
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
United States · Dec 5, 2024
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
United States · Dec 5, 2024

Similar past solicitations

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed)
United States · Aug 14, 2024
Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
United States · Jan 15, 2025
Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)
United States · Jan 8, 2025
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
United States · Dec 16, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.